Top Medical Searches

Current Medical News

Trial drug shows ‘impressive’ Alzheimer’s action: study

The outcome raised hopes that a treatment may finally be within reach for the memory- and independence-robbing Alzheimer's diseaseAn experimental drug cleared protein buildup in the brains of people with mild Alzheimer's disease and slowed their mental decline, the results of a preliminary trial showed. "Although potentially this is an exciting story, it is important to temper any excitement with considerable caution," said Robert Howard, a professor of old age psychiatry at University College London. Researchers in the United States and Switzerland tested aducanumab, developed by biotech firm Biogen, on 165 people with early-stage Alzheimer's disease for a period of one year.

Read More..

August 31st, 2016

Array BioPharma Announces FDA Acceptance of Binimetinib NDA for Patients with Advanced NRAS-Mutant Melanoma

BOULDER, Colo., Sept. 1, 2016 /PRNewswire/ — Array BioPharma (Nasdaq: ARRY) today announced that the FDA has accepted its New Drug Application (NDA) for binimetinib with a target action date under the Prescription Drug User Fee Act (PDUFA) of June… Read More..

August 31st, 2016

FDA Approves Blincyto (blinatumomab) For Use In Pediatric Patients With Philadelphia Chromosome-Negative Relapsed Or Refractory B-cell Precursor Acute Lymphoblastic Leukemia

THOUSAND OAKS, Calif., Sept. 1, 2016 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for Blincyto (blinatumomab) to include new… Read More..

August 31st, 2016

Kamada and Kedrion Seek FDA Approval of Human Rabies Immunoglobulin as a Post-Exposure Treatment

NESS ZIONA, Israel/Fort Lee, NJ — September 1, 2016 – Kamada Ltd. (NASDAQ and TASE: KMDA), a plasma-derived protein therapeutics company focused on orphan indications and Kedrion S.p.A., the parent company of Kedrion Biopharma Inc., a company… Read More..

August 31st, 2016

Did Trump, Mexican leader talk wall cost or not?

Who will pay for the border wall? Trump, Mexican president disagree on whether topic even came upThe GOP presidential nominee was asked by the media who would pay for a barrier after meeting with Enrique Peña Nieto.

Read More..

August 31st, 2016
Copyright 2008 © Drugs and Diseases. Developed by Axilosoft
Home | About Us | Privacy Policy | Contact Us